Unveiling the Tax Loophole Fueling Pharmaceutical Offshoring Amid Tariffs

A hidden provision in recent U.S. tax legislation encourages pharmaceutical companies to offshore production, undercutting tariff efforts aimed at curbing reliance on foreign manufacturing.